Evidence map›Paper›PMID 39125626›Full record

ArticleInternational journal of molecular sciences2024

Effects of Modulating BMP9, BMPR2, and AQP1 on BMP Signaling in Human Pulmonary Microvascular Endothelial Cells.

Nikolaos S Lotsios, Chrysi Keskinidou, Ioanna Dimopoulou, Anastasia Kotanidou, David Langleben, Stylianos E Orfanos, Alice G Vassiliou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nikolaos S LotsiosFirst Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, 106 76 Athens, Greece.
Chrysi KeskinidouFirst Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, 106 76 Athens, Greece.ORCID 0000-0002-4047-3588
Ioanna DimopoulouFirst Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, 106 76 Athens, Greece.ORCID 0000-0002-2219-7292
Anastasia KotanidouFirst Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, 106 76 Athens, Greece.ORCID 0000-0002-2508-500X
David LanglebenCenter for Pulmonary Vascular Disease, Azrieli Heart Center and Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.
Stylianos E OrfanosFirst Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, 106 76 Athens, Greece.
Alice G VassiliouFirst Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, 106 76 Athens, Greece.ORCID 0000-0003-4984-0476

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary arterial hypertension (PAH) is a chronic disease characterized by a progressive increase in mean pulmonary arterial pressure. Mutations in the

Indexed as

Aquaporin 1Bone Morphogenetic Protein Receptors, Type IIEndothelial CellsGrowth Differentiation Factor 2Signal TransductionTransforming Growth Factor beta1Bone Morphogenetic ProteinsCells, CulturedGene SilencingHumansLungMicrovesselsPulmonary Arterial HypertensionAQP1 protein, humanAquaporin 1BMP10 protein, humanBMPR2 protein, humanBone Morphogenetic Protein Receptors, Type IIBone Morphogenetic ProteinsGDF2 protein, humanGrowth Differentiation Factor 2TGFB1 protein, humanTransforming Growth Factor beta1AQP1BMP9BMPR2PAH

Identifiers

PMID39125626
PMCPMC11311989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.